Regular Article
Impairment of the Blood–Nerve and Blood–Brain Barriers in Apolipoprotein E Knockout Mice

https://doi.org/10.1006/exnr.2001.7631Get rights and content

Abstract

Apolipoprotein E (apoE) is well characterized as a plasma lipoprotein involved in lipid and cholesterol metabolism. Recent studies implicating apoE in Alzheimer's disease and successful recovery from neurological injury have stimulated much interest in the functions of apoE within the brain. To explore the functions of apoE within the nervous system, we examined apoE knockout (KO) mice. Previously, we showed that apoE KO mice have a delayed response to noxious thermal stimuli associated with a loss and abnormal morphology of unmyelinated fibers in the sciatic nerve. From these data, we hypothesized that apoE KO mice could have an impaired blood–nerve barrier (BNB). In this report, we demonstrate functionally impaired blood–nerve and blood–brain barriers (BBB) in apoE KO mice using immunofluorescent detection of serum protein leakage into nervous tissue as a diagnostic for decreased BNB and BBB integrity. Extensive extravasation of serum immunoglobulin G (IgG) is detected in the sciatic nerve, spinal cord, and cerebellum of apoE KO but not WT mice. In a subpopulation of apoE KO mice, IgG also extravasates into discrete cortical and subcortical locations, including hippocampus. Loss of BBB integrity was additionally confirmed by the ability of exogenously supplied Evans blue dye to penetrate the BBB and to colocalize with IgG immunoreactivity in CNS tissue. These observations support a role for apoE in maintaining the integrity of the BNB/BBB and suggest a novel relationship between apoE and neural injury.

References (86)

  • I Jung-Testas et al.

    J. Steroid Biochem. Mol. Biol.

    (1992)
  • R.N Kalaria et al.

    Increased collagen content of cerebral microvessels in Alzheimer's disease

    Brain Res.

    (1995)
  • R.N Kalaria

    Cerebral vessels in aging and Alzheimer's disease

    Pharmacol. Ther.

    (1996)
  • T Kuhlmann et al.

    Immunoglobulins induce increased myelin debris clearance by mouse macrophage

    Neurosci. Lett.

    (1999)
  • D.T Laskowitz et al.

    Apolipoprotein E suppresses glial secretion of TNFα

    J. Neuroimmunol.

    (1997)
  • L Lomnitski et al.

    Reduced levels of antioxidants in the brains of apolipoprotein E-deficient mice following closed head injury

    Pharmacol. Biochem. Behav.

    (1997)
  • B.P Nathan et al.

    The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization

    J. Biol. Chem.

    (1995)
  • M.F Newman et al.

    Predictors of cognitive decline after cardiac operation

    Ann. Thoracic Surg.

    (1995)
  • C Paul et al.

    Inhibition of blood–brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A

    Int. J. Immunopharmacol.

    (1995)
  • R.E Pitas et al.

    Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E lipoproteins

    Biochem. Biophys. Acta

    (1987)
  • A.S Plump et al.

    Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

    Cell

    (1992)
  • E Rechthand et al.

    Regulation of the microenvironment of the peripheral nerve: Role of the blood–nerve barrier

    Prog. Neurobiol.

    (1987)
  • G Stoll et al.

    Macrophages in the peripheral nervous system and astroglia in the central nervous system of rat commonly express apolipoprotein E during development but differ in their response to injury

    Neurosci. Lett.

    (1986)
  • B.E Tardiff et al.

    Preliminary report of a genetic basis for cognitive decline after cardiac operations

    Ann. Thoracic Surg.

    (1997)
  • G.M Teasdale et al.

    Association of apolipoprotein E polymorphisms with outcome after head injury

    Lancet

    (1997)
  • A Weerasuriya et al.

    Blood–nerve transfer of albumin and its implications for the endoneurial microenvironment

    Brain Res.

    (1989)
  • K.H Weisgraber et al.

    Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3

    J. Biol. Chem.

    (1986)
  • Y Abe et al.

    Anticytokine nature of natural human immunoglobulin: One possible mechanism of intravenous immunoglobulin therapy

    Immunol. Rev.

    (1994)
  • A Achiron et al.

    Intravenous immunoglobulin in multiple sclerosis: Clinical and neuroradiologic results and implications for possible mechanisms of action

    Clin. Exp. Immunol.

    (1996)
  • R.D Bart et al.

    Regional cerebral bloodflow in apolipoprotein E-deficient and wild-type mice during focal cerebral ischemia

    NeuroReport

    (1998)
  • H.C Bauer et al.

    Neural induction of the blood–brain barrier: Still an enigma

    Cell. Mol. Neurobiol.

    (2000)
  • B Beffert et al.

    The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease

    Brain Res. Rev.

    (1998)
  • S Bellosta et al.

    Stable expression and secretion of apolipoprotein E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth

    J. Biol. Chem.

    (1995)
  • J.K Boyles et al.

    Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system

    J. Clin. Invest.

    (1985)
  • F.M Brett et al.

    Evolution of neuropathologic abnormalities associated with blood–brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes

    J. Neuropathol. Exp. Neurol.

    (1995)
  • M.W Brightman et al.

    Permeable endothelium and the interstitial space of the brain

    Cell. Mol. Neurobiol.

    (2000)
  • G Bu et al.

    Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central nervous system

    J. Biol. Chem.

    (1995)
  • M.B Bunge et al.

    Perineurium originates from fibroblasts: Demonstration in vitro with a retroviral marker

    Science

    (1989)
  • J.P Casella et al.

    Development of endothelial paracellular clefts and their tight junctions in the pial microvessels of the rat

    J. Neurocytol.

    (1997)
  • R.A Clasen et al.

    Vital staining, serum albumin and the blood–brain barrier

    J. Neuropathol. Exp. Neurol.

    (1970)
  • N Bont et al.

    Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection

    J. Lipid Res.

    (1999)
  • B Dehouck et al.

    The upregulation of the low density lipoprotein receptor at the blood–brain barrier: Intercommunication between brain capillary endothelial cells and astrocytes

    J. Cell Biol.

    (1994)
  • Cited by (111)

    • Vascular ApoE4 Impairs Behavior by Modulating Gliovascular Function

      2021, Neuron
      Citation Excerpt :

      First, the phenotypes related to VMC-derived apoE were determined by comparing phenotypes in iE/Cre+ mice with those in iE/Cre− mice (Figures 1, 2, 3, 4, and S1–S5), both of which have the background of murine apoE deficiency. Several phenotypes including cognitive decline, synaptic degeneration (Masliah et al., 1995), BBB dysfunction (Bell et al., 2012; Fullerton et al., 2001), and hypercholesterolemia are reported in the absence of murine apoE. Thus, there is a possibility that subtle phenotypes mediated by VMC-derived apoE were not captured in the presence of phenotypes related to murine Apoe knockout.

    • ApoE and cerebral insulin: Trafficking, receptors, and resistance

      2020, Neurobiology of Disease
      Citation Excerpt :

      ApoE levels in the CSF are approximately 10-fold less than in the plasma (Chernick et al., 2019) but the correlation between apoE levels in these two pools is weak (Cruchaga et al., 2012). Regardless, apoE is important for BBB repair after injury (Bell et al., 2012; Donahue and Johanson, 2008; Fullerton et al., 2001). Here, we review the literature supporting the link between CNS insulin and apoE.

    • Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier

      2019, Neuroscience Letters
      Citation Excerpt :

      In particular, APOE4 increases the prevalence and severity of CAA [96,97]. In animal models, early studies indicated that ApoE deficiency leads to damage of the BBB [91,98–100]. More recently, it has been shown that the influence of APOE on BBB integrity, as well as cerebral blood flow, is isoform-dependent [101–103].

    • ApoE elevation is associated with the persistence of psychotic experiences from age 12 to age 18: Evidence from the ALSPAC birth cohort

      2019, Schizophrenia Research
      Citation Excerpt :

      ApoE is also relevant to psychosis risk through its impact on the integrity of the blood brain barrier (implicated in schizophrenia) (Pollak et al., 2018). ApoE knockout mice exhibit impaired blood-brain barrier integrity (Fullerton et al., 2001) and knockout mice are also vulnerable to psychosis-related behavioural responses following administration of human NMDAR-AB (Hammer et al., 2014). Finally, plasma apoE levels impact on cognition and synaptic function (Lane-Donovan et al., 2016), findings which may be relevant to the cognitive changes found among CHR subjects who transition to psychotic disorder (disorganized communication, poor social functioning and verbal memory deficits in particular) (Addington et al., 2017) and among subjects who report psychotic experiences at age 11 (processing speed and attention in particular) (Niarchou et al., 2013).

    View all citing articles on Scopus
    View full text